Filipe Moreira

Mr. Filipe Moreira

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2020 in Science
Verified
Journal Article
Open access
DCDarlan S. Candido
Darlan S. Candido
ICIngra M. Claro
Ingra M. Claro
JJJaqueline de Jesus
Jaqueline de Jesus
William SouzaWilliam Souza
William Souza
FMFilipe Moreira
Filipe Moreira
NFNuno Rodrigues Faria
Nuno Rodrigues Faria
The spread of SARS-CoV-2 in Brazil: Brazil has been hard-hit by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Candido et al. combined genomic and epidemiological analyses to investigate the impact of nonpharmaceutical interventions (NPIs) in the country. By setting up a network of genomic laboratories using harmonized protocols, the researchers found a 29% positive rate for SARS-CoV-2 among collected samples. More than 100 international introductions of SARS-CoV-2 into Brazil were identified, including three clades introduced from Europe that were already well established before the implementation of NPIs and travel bans. The virus spread from urban centers to the rest of the country, along with a 25% increase in the average distance traveled by air passengers before travel bans, despite an overall drop in short-haul travel. Unfortunately, the evidence confirms that current interventions remain insufficient to keep virus transmission under control in Brazil. Science , this issue p. 1255

26 August 2024 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
FMFilipe Moreira
Filipe Moreira
JDJoão Victor Rodrigues Dutra
João Victor Rodrigues Dutra
ACAndré Henrique Barbosa de Carvalho
André Henrique Barbosa de Carvalho
CRClarisse Rezende Reis
Clarisse Rezende Reis
JRJéssica Silqueira Hickson Rios
Jéssica Silqueira Hickson Rios
RARenato Aguiar
Renato Aguiar

20 November 2024 in BMC Medicine
Verified
Journal Article
Open access
PDF file
AJAugusto César Parreiras de Jesus
Augusto César Parreiras de Jesus
Paula FonsecaPaula Fonseca
Paula Fonseca
Hugo Jose AlvesHugo Jose Alves
Hugo Jose Alves
DBDiego Menezes Bonfim
Diego Menezes Bonfim
JDJoão Victor Rodrigues Dutra
João Victor Rodrigues Dutra
RARenato Aguiar
Renato Aguiar
The rapid spread and increase of chikungunya (CHIKV) and dengue (DENV) cases in Brazilian regions in 2023 has raised concerns about the impact of arboviruses on public health. Epidemiological and genomic surveillance was performed to estimate the introduction and spread of CHIKV and DENV in Brazil. This study obtained results from the Hermes Pardini (HP), a private medical laboratory, and the Health Department of Minas Gerais state (SES-MG). We investigated the positivity rates of CHIKV and DENV by analyzing the results of 139,457 samples tested for CHIKV (44,029 in 2022 and 95,428 in 2023) and 491,528 samples tested for DENV (163,674 in 2022 and 327,854 in 2023) across the five representative geographical regions of Brazil. Genome sequencing was performed on 80 CHIKV and 153 DENV samples that had been positive for RT-PCR tests. In our sampling, the data from CHIKV tests indicated that the Northeast region had the highest regional positivity rate in 2022 (58.1%). However, in 2023, the Southeast region recorded the highest positivity rate (40.5%). With regard to DENV, the South region exhibited the highest regional positivity rate in both 2022 (40.8%) and 2023 (22.7%), followed by the Southeast region in both years (34.8% in 2022; 21.4% in 2023). During the first 30 epidemiological weeks of 2023 in the state of Minas Gerais (MG), there was a 5.8-fold increase in CHIKV cases and a 3.5-fold increase in DENV compared to the same period in 2022. Analysis of 151 new DENV-1 and 80 CHIKV genomes revealed the presence of three main clusters of CHIKV and circulation of several DENV lineages in MG. All CHIKV clades are closely related to genomes from previous Brazilian outbreaks in the Northeast, suggesting importation events from this region to MG. We detected the RNA of both viruses in approximately 12.75% of the confirmed positive cases, suggesting an increase of co-infection with DENV and CHIKV during the period of analysis. These high rates of re-emergence and co-infection with both arboviruses provide useful data for implementing control measures of Aedes vectors and the urgent implementation of public health politics to reduce the numbers of CHIKV and DENV cases in the country.

20 April 2022 in Viruses
Verified
Journal Article
Open access
PDF file
JSJoice P. Silva
Joice P. Silva
ALAline Lima
Aline Lima
LALuige Alvim
Luige Alvim
FMFrederico Scott Varella Malta
Frederico Scott Varella Malta
CMCristiane Pinheiro Toscano de Brito Mendonça
Cristiane Pinheiro Toscano de Brito Mendonça
DZDanielle Alves Gomes Zauli
Danielle Alves Gomes Zauli
Coronavirus disease 2019 (COVID-19) pandemic has caused immeasurable impacts on the health and socioeconomic system. The real-time identification and characterization of new Variants of Concern (VOCs) are critical to comprehend its emergence and spread worldwide. In this sense, we carried out a national epidemiological surveillance program in Brazil from April to October 2021. Genotyping by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and sequencing were performed to monitor the dynamics and dissemination of VOCs in samples from 15 federative units. Delta VOC was first detected on June 2021 and took sixteen weeks to replace Gamma. To assess the transmissibility potential of Gamma and Delta VOCs, we studied the dynamics of RT-qPCR cycle threshold (Ct) score in the dominance period of each variant. The data suggest that Delta VOC has a higher transmission rate than Gamma VOC. We also compared relevant symptom patterns in individuals infected with both VOCs. The Delta-infected subjects were less likely to have low oxygen saturation or fatigue, altered results on chest computed tomography, and a propensity for altered X-rays. Altogether, we described the replacement of Gamma by Delta, Delta enhanced transmissibility, and differences in symptom presentation.

26 May 2021 in Viruses
Verified
Journal Article
Open access
PDF file
FMFilipe Moreira
Filipe Moreira
DBDiego Menezes Bonfim
Diego Menezes Bonfim
DZDanielle Alves Gomes Zauli
Danielle Alves Gomes Zauli
JSJoice P. Silva
Joice P. Silva
ALAline Lima
Aline Lima
RARenato Aguiar
Renato Aguiar
The emergence of diverse lineages harboring mutations with functional significance and potentially enhanced transmissibility imposes an increased difficulty on the containment of the SARS-CoV-2 pandemic

30 March 2023 in Viruses
Verified
Journal Article
Open access
PDF file
ALAlessandra Pavan Lamarca
Alessandra Pavan Lamarca
Ueric José Borges de SouzaUeric José Borges de Souza
Ueric José Borges de Souza
FMFilipe Moreira
Filipe Moreira
LALuiz G P de Almeida
Luiz G P de Almeida
MMMariane Talon Menezes
Mariane Talon Menezes
AVAna Tereza Ribeiro de Vasconcelos
Ana Tereza Ribeiro de Vasconcelos
Brazil currently ranks second in absolute deaths by COVID-19, even though most of its population has completed the vaccination protocol. With the introduction of Omicron in late 2021, the number of COVID-19 cases soared once again in the country. We investigated in this work how lineages BA.1 and BA.2 entered and spread in the country by sequencing 2173 new SARS-CoV-2 genomes collected between October 2021 and April 2022 and analyzing them in addition to more than 18,000 publicly available sequences with phylodynamic methods. We registered that Omicron was present in Brazil as early as 16 November 2021 and by January 2022 was already more than 99% of samples. More importantly, we detected that Omicron has been mostly imported through the state of São Paulo, which in turn dispersed the lineages to other states and regions of Brazil. This knowledge can be used to implement more efficient non-pharmaceutical interventions against the introduction of new SARS-CoV variants focused on surveillance of airports and ground transportation.